{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:48:34Z","timestamp":1761630514376,"version":"3.40.3"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2344,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,4]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>Acute graft-versus-host disease following orthotopic liver transplantation is a rare but feared complication arising in 1% to 2% of cases with a dismal prognosis. It most often presents as fever, rash, and diarrhea with or without pancytopenia. Patients die from complications of marrow failure such as sepsis or bleeding. Because of its low incidence, there is no clear treatment protocol for this complication. Both increasing and withdrawing immunosuppression have been attempted with variable success. Although anti\u2013tumor necrosis factor \u03b1 therapy has been widely used for the treatment of steroid-resistant acute graft-versus-host disease in the hematopoietic stem cell transplant setting, there previously have been no reported cases of its use in liver transplantation. The aim of this report is to review a case of acute graft-versus-host disease and the use of etanercept to manage this complication. Etanercept has never previously been used in liver transplantation complicated by acute graft-versus-host disease. In the hematology literature, the success of its use is offset by significant rates of serious infectious (especially fungal) complications. However, preliminary results are encouraging and offer insight into its use as a potentially viable therapeutic option. We report the first successful use of etanercept in liver transplantation\u2013associated graft-versus-host disease, albeit complicated by invasive aspergillosis, and recommend concurrent antifungal prophylaxis when the drug is used in this setting.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/lt.21704","type":"journal-article","created":{"date-parts":[[2009,3,26]],"date-time":"2009-03-26T16:39:30Z","timestamp":1238085570000},"page":"421-426","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":27,"title":["Acute graft-versus-host disease after liver transplant: Novel use of etanercept and the role of tumor necrosis factor \u03b1 inhibitors"],"prefix":"10.1097","volume":"15","author":[{"given":"Lena","family":"Thin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerry","family":"MacQuillan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leon","family":"Adams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Garas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"Seow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Cannell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley","family":"Augustson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc","family":"Delriveire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Jeffrey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-9-20250330","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/00007890-200301150-00022","article-title":"Liver transplantassociated graftversushost disease.","volume":"75","author":"Smith","year":"2003","journal-title":"Transplantation"},{"key":"R2-9-20250330","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1053\/jlts.2002.35552","article-title":"Acute graftversushost disease of the lung after liver transplantation.","volume":"8","author":"Knox","year":"2002","journal-title":"Liver Transpl"},{"key":"R3-9-20250330","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000100500","article-title":"Graft versus host disease after orthotopic liver transplantation documented by analysis of short tandem repeat polymorphisms.","volume":"74","author":"SchonigerHekele","year":"2006","journal-title":"Digestion"},{"key":"R4-9-20250330","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/01.TP.0000103721.29729.FE","article-title":"Monitoring systemic donor lymphocyte macrochimerism to aid the diagnosis of graftversushost disease after liver transplantation.","volume":"77","author":"Taylor","year":"2004","journal-title":"Transplantation"},{"key":"R5-9-20250330","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1002\/lt.21203","article-title":"Graft vs. host disease after liver transplantation: a new approach is needed.","volume":"13","author":"Perri","year":"2007","journal-title":"Liver Transpl"},{"key":"R6-9-20250330","first-page":"137","article-title":"Analysis of the VNTR locus D1S80 by the PCR followed by highresolution PAGE.","volume":"48","author":"Budowle","year":"1991","journal-title":"Am J Hum Genet"},{"key":"R7-9-20250330","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00007890-200201270-00030","article-title":"Successful outcome of acute graftversushost disease in a liver allograft recipient by withdrawal of immunosuppression.","volume":"73","author":"Lehner","year":"2002","journal-title":"Transplantation"},{"key":"R8-9-20250330","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/lt.20982","article-title":"Acute graftversushost disease after liver transplantation: role of withdrawal of immunosuppression in therapeutic management.","volume":"13","author":"Chinnakotla","year":"2007","journal-title":"Liver Transpl"},{"key":"R9-9-20250330","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.trim.2006.08.006","article-title":"Late onset of severe graftversushost disease following liver transplantation.","volume":"16","author":"Sun","year":"2006","journal-title":"Transpl Immunol"},{"key":"R10-9-20250330","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1600-6143.2004.00406.x","article-title":"Acute graft versus host disease following liver transplantation: the enemy within.","volume":"4","author":"Taylor","year":"2004","journal-title":"Am J Transplant"},{"key":"R11-9-20250330","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1002\/hep.510250528","article-title":"Peripheral blood chimerism following human liver transplantation.","volume":"25","author":"Jonsson","year":"1997","journal-title":"Hepatology"},{"key":"R12-9-20250330","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1097\/00007890-199310000-00042","article-title":"Persistence of donor lymphocytes in liver allograft recipients.","volume":"56","author":"Schlitt","year":"1993","journal-title":"Transplantation"},{"key":"R13-9-20250330","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1111\/j.1600-6143.2005.01110.x","article-title":"Acute graft versus host disease after liver transplantation: patterns of lymphocyte chimerism.","volume":"5","author":"DomiatiSaad","year":"2005","journal-title":"Am J Transplant"},{"key":"R14-9-20250330","first-page":"180","article-title":"Rapid method for the analysis of peripheral chimerism in suspected graftversushost disease after liver transplantation.","volume":"6","author":"Hahn","year":"2000","journal-title":"Liver Transpl"},{"key":"R15-9-20250330","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1034\/j.1399-0012.2000.140213.x","article-title":"Graftversushost disease after liver transplantation: documentation by fluorescent in situ hybridisation and human leucocyte antigen typing.","volume":"14","author":"Au","year":"2000","journal-title":"Clin Transplant"},{"key":"R16-9-20250330","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jaad.2006.04.073","article-title":"Acute graftversushost disease after liver transplantation diagnosed by fluorescent in situ hybridization testing of skin biopsy specimens.","volume":"55","author":"Meves","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"R17-9-20250330","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1097\/01.TP.0000145523.08548.48","article-title":"Recipients who receive a human leukocyte antigenB compatible cadaveric liver allograft are at high risk of developing acute graftversushost disease.","volume":"78","author":"Key","year":"2004","journal-title":"Transplantation"},{"key":"R18-9-20250330","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/lt.20101","article-title":"Graftversushost disease following living donor liver transplantation.","volume":"10","author":"Soejima","year":"2004","journal-title":"Liver Transpl"},{"key":"R19-9-20250330","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1056\/NEJM199303183281104","article-title":"Brief report: donorderived longterm multilineage hematopoiesis in a livertransplant recipient.","volume":"328","author":"Collins","year":"1993","journal-title":"N Engl J Med"},{"key":"R20-9-20250330","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/00007890-199302000-00033","article-title":"Confirmation of graftversushost disease after liver transplantation by PCR HLAtyping.","volume":"55","author":"Mazzaferro","year":"1993","journal-title":"Transplantation"},{"key":"R21-9-20250330","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/hep.1840140212","article-title":"Graft vs. host disease after liver transplantation in humans: a report of four cases.","volume":"14","author":"Roberts","year":"1991","journal-title":"Hepatology"},{"key":"R22-9-20250330","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1155\/2000\/678043","article-title":"Graftversushost disease after liver transplantation complicated by systemic aspergillosis with pancarditis.","volume":"14","author":"Romagnuolo","year":"2000","journal-title":"Can J Gastroenterol"},{"key":"R23-9-20250330","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/01.tp.0000190431.94252.3f","article-title":"Use of short tandem repeats for DNA fingerprinting to rapidly diagnose graftversushost disease in solid organ transplant patients.","volume":"81","author":"Schrager","year":"2006","journal-title":"Transplantation"},{"key":"R24-9-20250330","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1046\/j.1365-2133.1999.03166.x","article-title":"Cutaneous lesions as the presenting sign of acute graftversushost disease following liver transplantation.","volume":"141","author":"Schmuth","year":"1999","journal-title":"Br J Dermatol"},{"key":"R25-9-20250330","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/hep.1840170629","article-title":"Cell migration and chimerism after wholeorgan transplantation: the basis of graft acceptance.","volume":"17","author":"Starzl","year":"1993","journal-title":"Hepatology"},{"key":"R26-9-20250330","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jaad.2005.01.126","article-title":"Rash and pancytopenia as initial manifestations of acute graftversushost disease after liver transplantation.","volume":"52","author":"Whalen","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"R27-9-20250330","first-page":"3616","article-title":"Fatal graftversushostdisease: a grave complication after orthotopic liver transplantation.","volume":"26","author":"Neumann","year":"1994","journal-title":"Transplant Proc"},{"key":"R28-9-20250330","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1399-0012.1995.tb00299.x","article-title":"Lethal acute graftversushost disease in a liver transplant recipient: relations with cell migration and chimerism.","volume":"9","author":"Pageaux","year":"1995","journal-title":"Clin Transplant"},{"key":"R29-9-20250330","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/j.1445-5994.1998.tb01563.x","article-title":"Successful resolution of severe graft versus host disease after liver transplantation correlating with disappearance of donor DNA from the peripheral blood.","volume":"28","author":"Paizis","year":"1998","journal-title":"Aust N Z J Med"},{"key":"R30-9-20250330","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1034\/j.1600-6143.2003.00108.x","article-title":"Treatment of graftversushost disease after liver transplantation with basiliximab followed by bowel resection.","volume":"3","author":"Sudhindran","year":"2003","journal-title":"Am J Transplant"},{"key":"R31-9-20250330","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0041-1345(01)02828-7","article-title":"Selective immunosuppression with daclizumab in liver transplantation with graftversushost disease.","volume":"34","author":"Rinon","year":"2002","journal-title":"Transplant Proc"},{"key":"R32-9-20250330","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1097\/01.TP.0000144183.77279.EC","article-title":"Control of organ transplantassociated graftversushost disease by activated host lymphocyte infusions.","volume":"78","author":"Kuball","year":"2004","journal-title":"Transplantation"},{"key":"R33-9-20250330","first-page":"1352","article-title":"Infliximab treatment for steroidrefractory acute graftversushost disease.","volume":"89","author":"Patriarca","year":"2004","journal-title":"Haematologica"},{"key":"R34-9-20250330","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1182\/blood-2003-12-4241","article-title":"Tumor necrosis factoralpha blockade for the treatment of acute GVHD.","volume":"104","author":"Couriel","year":"2004","journal-title":"Blood"},{"key":"R35-9-20250330","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ajh.10392","article-title":"Infliximab for steroidrefractory acute GVHD: a case series.","volume":"74","author":"Jacobsohn","year":"2003","journal-title":"Am J Hematol"},{"key":"R36-9-20250330","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/sj.bmt.1703094","article-title":"Treatment of severe steroid refractory acute graftversushost disease with infliximab, a chimeric humanmouse antiTNFalpha antibody.","volume":"28","author":"Kobbe","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"R37-9-20250330","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.bbmt.2005.05.009","article-title":"Pilot trial on the use of etanercept and methylprednisolone as primary treatment for acute graftversushost disease.","volume":"11","author":"Uberti","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"R38-9-20250330","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/sj.bmt.1705380","article-title":"Combination antithymocyte globulin and soluble TNFalpha inhibitor (etanercept) mycophenolate mofetil for treatment of steroid refractory acute graftversushost disease.","volume":"37","author":"Kennedy","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"R39-9-20250330","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/ajh.20752","article-title":"Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graftversushost disease following allogeneic hematopoietic stem cell transplantation.","volume":"82","author":"Busca","year":"2007","journal-title":"Am J Hematol"},{"key":"R40-9-20250330","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1182\/blood-2007-09-112987","article-title":"Etanercept plus methylprednisolone as initial therapy for acute graftversushost disease.","volume":"111","author":"Levine","year":"2008","journal-title":"Blood"}],"container-title":["Liver Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Flt.21704","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01445473-200904000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T23:40:37Z","timestamp":1743378037000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01445473-200904000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1002\/lt.21704","relation":{},"ISSN":["1527-6465"],"issn-type":[{"type":"print","value":"1527-6465"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}